Contract W58P0522C0017
Moderna Us, Inc. · Department Of Defense · July 29, 2022
Moderna Us, Inc. was awarded a federal contract by Department Of Defense (Department Of The Army) on July 29, 2022 for $1.79 billion of work in pharmaceutical preparation manufacturing. Performance is in Cambridge, MA. It was awarded under full and open competition. The contract has been modified 3 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on November 9, 2022. If all options are exercised, the contract could reach $7.84 billion.
Contract details
- PIID
- W58P0522C0017
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Cambridge, MA
- First action
- July 29, 2022
- Latest action
- November 9, 2022
Description
COVID-19 VACCINE MRNA 1273.222
Modification timeline
-
November 9, 2022Mod P00003$-1
-
September 30, 2022Mod P00002$0
-
August 1, 2022Mod P00001COVID-19 MRNA VACCINES: EXECUTION AND FUNDING OF OPTION CLINS 0004 & 0006 FOR 400K VIALS PEDS (0.5-5YRS) DOSES.$52.60M
-
July 29, 2022Base awardCOVID-19 MRNA VACCINES$1.74B
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $51 |
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $91 |
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $32 |
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $1.1K |
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $22 |
| Cardinal Health, Inc. | Department Of Defense | December 31, 2025 | $23 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract W58P0522C0017?
Contract W58P0522C0017 is a federal contract awarded to Moderna Us, Inc. by Department Of Defense on July 29, 2022 for $1.79 billion of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 3 times since the base award.
Who won contract W58P0522C0017?
Moderna Us, Inc. won contract W58P0522C0017 from Department Of Defense.
How much is contract W58P0522C0017 worth?
Contract W58P0522C0017 has obligated $1.79 billion to date, with a total potential value of $7.84 billion if all options are exercised.